ClinicaliQ Trial Snapshot
- Mechanism of Chronic Pain in Patients With IBD — Recruiting • Cardiology / Cardiovascular • NCT04995224.
- What is being tested: This trial investigates the underlying biological mechanisms causing chronic abdominal pain in IBD patients, particularly why pain persists even during disease remission when inflammation is controlled.
- Patient eligibility overview: The study includes adult IBD patients (both Crohn's disease and ulcerative colitis) with chronic abdominal pain, encompassing those with active disease and those in clinical remission.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Abdominal pain is a common symptom in patients with inflammatory bowel disease (IBD). Up to 70 % of IBD patients experience pain when the disease is active. Even when patients with IBD are in remission, 20-50 % experience ongoing pain. The precise mechanism of developing chronic abdominal pain in patients with IBD in remission remains unknown. The aim of this study is to identify psychophysiological and biological risk factors for the development of chronic abdominal pain in patients with newly diagnosed IBD (ulcerative colitis and Crohn's disease). This study consists…
Eligibility Snapshot
- : * Males or females who are over 18 years old. * Patients who are diagnosed with UC or CD within 6 months before the enrolment. * Patients who have access to the internet and have the IT skills to perform basic tasks e.g. operate emails and fill out questionnaires. * Patients who are willing and able to participate in the study for the required duration, can understand and are willing to sign the consent forms and agree to undergo all protocol-related tests and procedures.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.